Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) CEO R. Allison sold 98,958 shares of the company’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $123.27, for a total value of $12,198,552.66. Following the completion of the sale, the chief executive officer owned 183,150 shares of the company’s stock, valued at approximately $22,576,900.50. This trade represents a 35.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Addus HomeCare Price Performance
NASDAQ:ADUS opened at $126.29 on Wednesday. The business’s 50-day moving average price is $117.97 and its 200 day moving average price is $107.02. The firm has a market cap of $2.35 billion, a P/E ratio of 21.05, a PEG ratio of 1.62 and a beta of 0.75. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $131.59. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.02.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. During the same period in the previous year, the business earned $1.56 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, sell-side analysts predict that Addus HomeCare Corporation will post 6.36 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on ADUS shares. Raymond James Financial set a $137.00 target price on shares of Addus HomeCare in a report on Monday, September 28th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Saturday. Citigroup cut shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Barclays lifted their price target on shares of Addus HomeCare from $96.00 to $101.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 4th. Finally, Weiss Ratings raised Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $134.70.
Check Out Our Latest Stock Report on Addus HomeCare
Trending Headlines about Addus HomeCare
Here are the key news stories impacting Addus HomeCare this week:
- Neutral Sentiment: Addus said it will participate in the 2026 Stephens Annual Investment Conference. The announcement provides an opportunity to meet investors but gives no new financial or operating guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
- Neutral Sentiment: A report listed short interest at zero shares, indicating no reported short position; however, its description of a “large increase” conflicts with that figure.
- Negative Sentiment: Several executives disclosed stock sales. CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his holding by 35.08%. Five EVPs collectively sold 32,697 shares for roughly $4.1 million. Insider sales can weigh on sentiment, although they do not by themselves establish a negative outlook. CEO sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing
Hedge Funds Weigh In On Addus HomeCare
Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in Addus HomeCare during the 2nd quarter worth about $344,153,000. Dimensional Fund Advisors LP boosted its holdings in shares of Addus HomeCare by 11.8% in the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after buying an additional 78,415 shares during the period. Bank of America Corp DE acquired a new position in shares of Addus HomeCare in the second quarter worth about $35,527,000. TimesSquare Capital Management LLC acquired a new position in shares of Addus HomeCare in the second quarter worth about $31,502,000. Finally, Boston Partners increased its position in shares of Addus HomeCare by 18.0% in the third quarter. Boston Partners now owns 290,332 shares of the company’s stock worth $32,222,000 after acquiring an additional 44,279 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Read More
- Five stocks we like better than Addus HomeCare
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
